Medical Device News Magazine

Jill Canada Appointed VP of Corporate and Enterprise Sales at Avail Medsystems

Ms. Canada Will Guide Device Industry and Healthcare System Clients in Using Avail's Surgical Telepresence Platform to Solve Business Challenges

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

Avail Medsystems, a pioneering healthcare technology company whose innovative surgical telepresence platform facilitates real-time collaboration between medical professionals during live procedures, announced today that it has named Jill Canada its Vice President of Corporate and Enterprise Sales.

A recognized commercial leader who has spent nearly 20 years helping clients gain a competitive advantage by developing strategies to strengthen revenue and operating margin, Jill Canada will lead a team at Avail in fostering supportive, productive relationships with key medical device industry and healthcare system clients.

“By putting industry experts in procedure rooms when they can’t otherwise be on site, we’re enabling access to expertise not just when it’s convenient, but when needed,” Avail Founder and CEO Daniel Hawkins said. “Jill’s consultative approach is an ideal fit for our medical device and health system clients as they look to implement digital solutions to make servicing their physician customers and patients more efficient and effective.”

“The team at Avail is one of the most committed groups I’ve seen during my career, united by a passion to improve healthcare through technology. Jill is the perfect complement,” stated Ryan Magnes, President, Avail. “She brings the experience necessary to connect the right clients with solutions to support their efforts to standardize access to excellent healthcare, improve physician satisfaction, reduce costs, and expand reach of the most relevant experts.”

Since 2013, Ms. Canada has worked for GE Healthcare, most recently as Executive, Strategic Clients and before that as Senior Director, Strategic Clients. Prior to GE, Jill was a Strategic Account Specialist for Roche Diagnostics and Vice President of Business Development for SafeScan Imaging Services.

“I’m thrilled to join the team at Avail, where my goal is to help improve the way healthcare is delivered,” Ms. Canada said. “I’m committed to leading a team that cultivates true partnerships, fostering the success of pivotal healthcare stakeholders through the application of Avail’s telepresence platform. My work will be fueled by Avail’s mission to level the playing field for treatment facilities, physicians, and patients everywhere by bringing the world’s clinical expertise into any procedure room, anytime, at the click of a button.”

With Ms. Canada’s hire, Avail furthers its continued organizational expansion including moving from a business incubator into a larger headquarters in May 2021, a $100 million Series B funding round, the ongoing expansion of contracts with medical device industry clients, and the addition of console locations across the US.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”